Evidence map›Paper›PMID 30789980›Full record

ArticleThe Journal of clinical endocrinology and metabolism2019

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.

Devjit Tripathy, Aurora Merovci, Rita Basu, Muhammad Abdul-Ghani, Ralph A DeFronzo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects.The Journal of clinical endocrinology and metabolism · 2022
    Article
  14. Ten things to know about ten cardiovascular disease risk factors - 2022.American journal of preventive cardiology · 2022
    Review
  15. Article
  16. Ten things to know about ten cardiovascular disease risk factors.American journal of preventive cardiology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Uncontrolled Diabetes as an Associated Factor with Dynapenia in Adults Aged 50 Years or Older: Sex Differences.The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Devjit TripathyDepartment of Medicine, Diabetes Division, University of Texas Health Science, San Antonio, Texas.
Aurora MerovciDepartment of Medicine, Diabetes Division, University of Texas Health Science, San Antonio, Texas.
Rita BasuDepartment of Medicine, Endocrinology Division, University of Virginia School of Medicine, Charlottesville, Virginia.
Muhammad Abdul-GhaniDepartment of Medicine, Diabetes Division, University of Texas Health Science, San Antonio, Texas.
Ralph A DeFronzoDepartment of Medicine, Diabetes Division, University of Texas Health Science, San Antonio, Texas.
The University of Texas Health Science Center at San Antonio · USUniversity of Virginia · US

Funding

SGLT2 Inhibitors, Ketogenesis, and KetoacidosisR01DK024092 · NIDDK · YALE UNIVERSITY · PI RALPH A DEFRONZO · 1986 to 2026
$12.7M
MECHANISMS OF INSULIN RESISTANCE IN MANR01DK029953 · NIDDK · UNIVERSITY OF VIRGINIA · PI BASU, RITA · 1986 to 2024
$11.5M
MECHANISMS OF INSULIN RESISTANCE in ManR37DK029953 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI RIZZA, ROBERT A. · 1996 to 2003
$1.8M
Regulation of Hepatic and Peripheral Glucose MetabolismR56DK024092 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DEFRONZO, RALPH A · 2005 to 2005
$73k
NIDDK NIH HHS R01 DK024092NIDDK NIH HHS R01 DK029953NIDDK NIH HHS R37 DK029953NIDDK NIH HHS R56 DK024092
6 · The paper itself

Abstract

contextChronic hyperglycemia worsens skeletal muscle insulin resistance and β-cell function. However, the effect of sustained physiologic hyperglycemia on hepatic insulin sensitivity is not clear.

objectiveTo examine the effect of sustained physiologic hyperglycemia (similar to that observed in patients with type 2 diabetes) on endogenous (primarily reflecting hepatic) glucose production (EGP) in healthy individuals.

designVolunteers participated in a three-step hyperinsulinemic (10, 20, 40 mU/m2 per minute) euglycemic clamp before and after a 48-hour glucose infusion to increase plasma glucose concentration by ∼40 mg/dL above baseline. EGP was measured with 3-3H-glucose before and after chronic glucose infusion.

participantsSixteen persons with normal glucose tolerance [eight with and eight without a family history (FH) of diabetes] participated in the study.

main outcome measureEGP.

resultsBasal EGP increased following 48 hours of glucose infusion (from a mean ± SEM of 2.04 ± 0.08 to 3.06 ± 0.29 mg/kgffm⋅ min; P < 0.005). The hepatic insulin resistance index (basal EGP × fasting plasma insulin) markedly increased following glucose infusion (20.1 ± 1.8 to 51.7 ± 6.6; P < 0.005) in both FH+ and FH- subjects.

conclusionSustained physiologic hyperglycemia for as little as 48 hours increased the rate of basal hepatic glucose production and induced hepatic insulin resistance in health persons with normal glucose tolerance, providing evidence for the role of glucotoxicity in the increase in hepatic glucose production in type 2 diabetes.

Indexed as

AdultBlood GlucoseC-PeptideFemaleGlucagonGluconeogenesisGlucoseGlucose Clamp TechniqueGlycogenolysisHealthy VolunteersHumansHyperglycemiaInsulinInsulin ResistanceLiverMaleBlood GlucoseC-PeptideGlucagonGlucoseInsulinTritium

Identifiers

PMID30789980
PMCPMC6543508
OpenAlexW2915913567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.